| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/07/2011 | US20110081363 Compositions and methods for biological sample storage |
| 04/07/2011 | US20110081360 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 04/07/2011 | US20110081359 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 04/07/2011 | US20110081349 Allergenic latex protein |
| 04/07/2011 | US20110081346 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 04/07/2011 | US20110081344 Soluble zcytor 11 cytokine receptors |
| 04/07/2011 | US20110081324 Collagen peptide conjugates and uses therefor |
| 04/07/2011 | US20110081292 Methods Of Treating Viral Hepatitis |
| 04/07/2011 | DE20321836U1 Hydroxyalkylstärkederivate Hydroxyalkylstärkederivate |
| 04/07/2011 | DE102009045268A1 Neue Marker für die Diagnose von Zöliakie New marker for the diagnosis of celiac disease |
| 04/07/2011 | DE102009039705A1 Peptide des CENP-A und ihre Verwendung Peptides of the CENP-A and their use |
| 04/07/2011 | CA2779506A1 Methods of improving vaccine immunogenicity |
| 04/07/2011 | CA2776778A1 Peptides |
| 04/07/2011 | CA2776534A1 Piscine reovirus diagnostic compositions |
| 04/07/2011 | CA2776529A1 Synthetic myostatin peptide antagonists |
| 04/07/2011 | CA2776503A1 Compositions and methods for enhancing coagulation factor viii function |
| 04/07/2011 | CA2776386A1 Piscine reovirus immunogenic compositions |
| 04/07/2011 | CA2776271A1 Anti-hsv antibody |
| 04/07/2011 | CA2776195A1 Hepatitis c virus vaccine composition |
| 04/07/2011 | CA2776143A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
| 04/07/2011 | CA2776004A1 Expression of meningococcal fhbp polypeptides |
| 04/07/2011 | CA2775980A1 Spider mite silk proteins |
| 04/07/2011 | CA2775945A1 Use of sirna targetting sipa1l1 for the reduction of adipogenesis |
| 04/07/2011 | CA2775846A1 T-cell receptor capable of recognising an antigen from cytomegalovirus |
| 04/07/2011 | CA2775720A1 Peptides for inducing heterosubtypic influenza t cell responses |
| 04/07/2011 | CA2775582A1 Insecticidal proteins |
| 04/07/2011 | CA2775358A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/07/2011 | CA2775353A1 Polypeptides derived from thermoascus crustaceu having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/07/2011 | CA2775347A1 Polypeptides having xylanase activity and polynucleotides encoding same |
| 04/07/2011 | CA2774552A1 Drug fusions and conjugates with extended half life |
| 04/06/2011 | EP2305836A1 Compositions, kits and methods for identification, assessment, prevention and therapy of cervical cancer |
| 04/06/2011 | EP2305824A1 Multiple inducible gene regulation system |
| 04/06/2011 | EP2305823A1 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 04/06/2011 | EP2305822A2 Methods and compositions for diseases associated with Amyloidosis |
| 04/06/2011 | EP2305818A2 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 04/06/2011 | EP2305816A1 Mutation in the Parkin gene, compositions, methods and uses |
| 04/06/2011 | EP2305815A1 Method for producing a peptide with a pI above 8 or below 5 |
| 04/06/2011 | EP2305804A1 MonoPEGylated human growth hormone |
| 04/06/2011 | EP2305802A1 Modified vitamin K-dependent polypeptides |
| 04/06/2011 | EP2305715A2 Monoclonal antibody to osteoprotegerin binding protein |
| 04/06/2011 | EP2305709A1 Recombinant antibodies specific for beta-amyloid ends, DNA encoding and methods for use thereof |
| 04/06/2011 | EP2305708A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 04/06/2011 | EP2305707A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 04/06/2011 | EP2305706A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 04/06/2011 | EP2305704A1 Fucose 1 6-specific lectin |
| 04/06/2011 | EP2305703A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/06/2011 | EP2305702A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 04/06/2011 | EP2305701A1 Tuberculosis antigen detection assays and vaccines |
| 04/06/2011 | EP2305700A1 Therapeutic USPA1-derived peptides |
| 04/06/2011 | EP2305699A1 Stabilised mRNA with increased G/C content which is optimised for translation in its coded areas |
| 04/06/2011 | EP2305314A2 Remodelling and glycoconjugation of antibodies |
| 04/06/2011 | EP2305313A2 Remodelling and glycoconjugation of interferon-alpha (IFNa) |
| 04/06/2011 | EP2305312A2 Remodelling and glycoconjugation of follicle-stimulating hormone (FSH) |
| 04/06/2011 | EP2305311A2 Glycoconjugation of peptides |
| 04/06/2011 | EP2305303A2 Immunization against Clostridium difficile disease |
| 04/06/2011 | EP2305302A2 Prevention and treatment of amyloidogenic disease |
| 04/06/2011 | EP2305299A1 Chimeric alphavirus replicon particles |
| 04/06/2011 | EP2305293A2 Immunization against Clostridium difficile disease |
| 04/06/2011 | EP2305282A2 Prevention and treatment of amyloidogenic disease |
| 04/06/2011 | EP2305247A2 Methods for detecting and reversing resistance to macrocyclic lactone compounds |
| 04/06/2011 | EP2305027A2 Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom |
| 04/06/2011 | EP2304444A1 Modulators of stat3 signalling |
| 04/06/2011 | EP2304441A2 A method for the screening of conserved secreted proteins |
| 04/06/2011 | EP2304435A1 Novel mitochondrial dye |
| 04/06/2011 | EP2304041A1 Method of producing yeast biomass |
| 04/06/2011 | EP2304038A2 Brassica plant comprising a mutant indehiscent allelle |
| 04/06/2011 | EP2304037A1 Plants having enhanced yield-related traits and a method for making the same |
| 04/06/2011 | EP2304024A2 Avian reoviridae |
| 04/06/2011 | EP2303925A2 Pigf-1 assay and kits and components thereof |
| 04/06/2011 | EP2303924A2 Lm-antibodies, functional fragments, lm-1 target antigen, and methods for making and using same |
| 04/06/2011 | EP2303922A1 Method for the in vitro diagnosis of stroke |
| 04/06/2011 | EP2303921A2 Mutated netrin-4 proteins, fragments thereof and their uses as drugs |
| 04/06/2011 | EP2303920A2 AMYLOID ß PEPTIDE ANALOGUES, OLIGOMERS THEREOF, PROCESSES FOR PREPARING AND COMPOSITIONS COMPRISING SAID ANALOGUES OR OLIGOMERS, AND THEIR USES |
| 04/06/2011 | EP2303919A1 Novel canola protein isolate |
| 04/06/2011 | EP2303917A2 Antagonists of actriib and uses for increasing red blood cell levels |
| 04/06/2011 | EP2303911A1 An synthetic peptide containing bone forming peptide 2(bfp 2) for stimulating osteoblast differentiation, and pharmaceutical composition comprising the synthetic peptide |
| 04/06/2011 | EP2303910A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 04/06/2011 | EP2303909A1 Iqgap3 epitope peptides and vaccines containing the same |
| 04/06/2011 | EP2303326A2 Treatment of solid tumors with tissue inhibitors of metalloproteinases (timps) |
| 04/06/2011 | EP2303323A1 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 04/06/2011 | EP2303322A1 Recombinant modified vaccinia virus measles vaccine |
| 04/06/2011 | EP2303320A1 Attenuated pestivirus |
| 04/06/2011 | EP2303318A2 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains |
| 04/06/2011 | EP2303317A2 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains |
| 04/06/2011 | EP2303316A1 Constructing a dna chimera for vaccine development against leishmaniasis and tuberculosis |
| 04/06/2011 | EP2303314A1 Chloramphenicol acetyl transferase (cat)-defective somatostatin fusion protein and uses thereof |
| 04/06/2011 | EP2303311A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders |
| 04/06/2011 | EP2303303A2 Methods of effecting wnt signaling through dkk structural analysis |
| 04/06/2011 | EP2303002A2 Novel gpr101 transgenic mice and methods of use thereof |
| 04/06/2011 | EP2123754B1 CHIMERIC Fc GAMMA RECEPTOR AND METHOD FOR DETERMINATION OF ADCC ACTIVITY BY USING THE RECEPTOR |
| 04/06/2011 | EP1973938B1 Luminescent stem cells and uses thereof |
| 04/06/2011 | EP1899373B1 Cspcna isoform modifications and uses thereof |
| 04/06/2011 | EP1866330B1 Method and device for detecting feline immunodeficiency virus |
| 04/06/2011 | EP1841781B1 Il-22 for use in the treatment of obesity, diabetes, hyperlipidemia, hyperglycemia and hyperinsulinemia |
| 04/06/2011 | EP1723425B1 Method and device for detecting feline immunodeficiency virus |
| 04/06/2011 | EP1709081B1 Fusion polypeptides capable of activating receptors |
| 04/06/2011 | EP1651750B1 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 04/06/2011 | EP1648501B1 Hybrid toxins comprising shiga-like toxin subunits fused to escherichia coli heat labile enterotoxin subunits and vaccines thereof |
| 04/06/2011 | EP1594889B1 Nell peptide expression systems and bone formation activity of nell peptide |
| 04/06/2011 | EP1529113B1 Vaccinia virus host range genes to increase the titer of avipoxviruses |